GYNAECOLOGYOntario Cervical Cancer Screening Clinical Practice Guidelines
REFERENCES (45)
- et al.
Prospective follow–up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy
Am J Obstet Gynecol
(2003) Cervical cancer screening in England
Eur J Cancer
(2000)- et al.
Women who participate in spontaneous screening are not at higher risk for cervical cancer than women who attend programme screening
Eur J Cancer
(2002) - et al.
The cervical cancer epidemic that screening has prevented in the UK
Lancet
(2004) - et al.
Screening interval and risk of invasive squamous cell cervical cancer
Obstet Gynecol
(2003) Canadian cancer statistics, 2004
(2004)- et al.
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation
J Clin Oncol
(1995) - et al.
Screening for cervical cancer: systematic evidence review No. 25. (Prepared by the Research Triangle Institute–University of North Carolina Evidence–based Practice Center under contract No. 290–97–0011)
(January 2002) - et al.
American Cancer Society guideline for the early detection of cervical neoplasia and cancer
CA Cancer J Clin
(2002) ACOG practice bulletin: clinical management guidelines for obstetrician–gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995)
Obstet Gynecol
(2003)
Recommendations for cervical screening 1997
NZ Med J
(1998)
2001 consensus guidelines for the management of women with cervical cytological abnormalities
JAMA
(2002)
Screening for cervical cancer
Guidelines for the management of asymptomatic women with screen detected abnormalities
(2004)
IARC confirms efficacy of cervix cancer screening for women 25–65 in reducing mortality
Press Release No.: 151. IARC Cervix Cancer Screening Meeting
(2004 Apr 20–27)
Liquid–based cytology and human papillomavirus testing in cervical cancer screening. Ottawa: Canadian Coordinating Office for Health Technology Assessment
Technology Report No.
(2003)
Liquid–based cervical cytology
(2003 Aug)
Liquid based cytology for cervical screening
(August 2002)
Evaluation of cervical cytology
(1999)
A systematic review of the role of human papillomavirus testing within a cervical screening programme
Health Technol Assess
(1999)
Virologic versus cytologic triage of women with equivocal Pap smears: a meta–analysis of the accuracy to detect high–grade intraepithelial neoplasia
J Natl Cancer Inst
(2004)
Cited by (12)
HPV Testing in Primary Cervical Screening: A Systematic Review and Meta-Analysis
2012, Journal of Obstetrics and Gynaecology CanadaCervical Screening: A Guideline for Clinical Practice in Ontario
2012, Journal of Obstetrics and Gynaecology CanadaThe Adolescent Transplant Recipient
2010, Pediatric Clinics of North AmericaCitation Excerpt :If this is not feasible, HPV immunization should be performed starting 1 year after transplant, when target immunosuppression levels are lower. Pap smears should be performed in sexually active adolescent girls on a schedule similar to that recommended for those who are HIV positive, yearly and indefinitely.27 Nonviral STI include chlamydia and gonorrhea.
Development of the Canadian Women-Centred HIV Care Model Using the Knowledge-to-Action Framework
2021, Journal of the International Association of Providers of AIDS CarePotential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine
2014, International Journal of Cancer
Competing Interests: See Acknowledgements
Copyright © 2007 Society of Obstetricians and Gynaecologists of Canada. Published by Elsevier Inc. All rights reserved.